Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Brisson

Showing results (51-60 of 145) with videos related to

Pageof 15
Sort By:
The Journal of Infectious Diseases|May 29, 2016
Comparison of 2-Dose and 3-Dose 9-Valent Human Papillomavirus Vaccine Schedules in the United States: A Cost-effectiveness AnalysisJean-François Laprise, Lauri E Markowitz, Harrell W Chesson, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 12, 2002
Direct cocktail analysis of drug discovery compounds in pooled plasma samples using liquid chromatography-tandem mass spectrometryYunsheng Hsieh, Matthew S Bryant, Jean-Marc Brisson, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 1, 2010
Prevention strategies for herpes zoster and post-herpetic neuralgiaMyron J Levin, Anne A Gershon, Robert H Dworkin, et al.
International Journal of Cancer|November 1, 2013
Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccineMélanie Drolet, Jean-François Laprise, Marie-Claude Boily, et al.
Vaccine|March 5, 2010
Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zosterMarc Brisson, Gurgen Melkonyan, Melanie Drolet, et al.
The Journal of Infectious Diseases|July 12, 2011
Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunityMarc Brisson, Nicolas van de Velde, Eduardo L Franco, et al.
Plos One|July 11, 2013
Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness?Mélanie Drolet, Marie-Claude Boily, Nicolas Van de Velde, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 20, 2012
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5Richard Pitman, David Fisman, Gregory S Zaric, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2012
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--5Richard Pitman, David Fisman, Gregory S Zaric, et al.
Vaccine|February 7, 2013
The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: a model-based analysisTalía Malagón, Véronique Joumier, Marie-Claude Boily, et al.
Pageof 15

Showing results (51-60 of 145) with videos related to

Sort By:
Pageof 15
The Journal of Infectious Diseases|May 29, 2016
Comparison of 2-Dose and 3-Dose 9-Valent Human Papillomavirus Vaccine Schedules in the United States: A Cost-effectiveness AnalysisJean-François Laprise, Lauri E Markowitz, Harrell W Chesson, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 12, 2002
Direct cocktail analysis of drug discovery compounds in pooled plasma samples using liquid chromatography-tandem mass spectrometryYunsheng Hsieh, Matthew S Bryant, Jean-Marc Brisson, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 1, 2010
Prevention strategies for herpes zoster and post-herpetic neuralgiaMyron J Levin, Anne A Gershon, Robert H Dworkin, et al.
International Journal of Cancer|November 1, 2013
Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccineMélanie Drolet, Jean-François Laprise, Marie-Claude Boily, et al.
Vaccine|March 5, 2010
Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zosterMarc Brisson, Gurgen Melkonyan, Melanie Drolet, et al.
The Journal of Infectious Diseases|July 12, 2011
Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunityMarc Brisson, Nicolas van de Velde, Eduardo L Franco, et al.
Plos One|July 11, 2013
Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness?Mélanie Drolet, Marie-Claude Boily, Nicolas Van de Velde, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 20, 2012
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5Richard Pitman, David Fisman, Gregory S Zaric, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2012
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--5Richard Pitman, David Fisman, Gregory S Zaric, et al.
Vaccine|February 7, 2013
The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: a model-based analysisTalía Malagón, Véronique Joumier, Marie-Claude Boily, et al.
Pageof 15